CXCR Family and Hematologic Malignancies in the Bone Marrow Microenvironment
Malignant hematologic diseases, also referred to as hematologic tumors, encompass a series of malignant proliferative disorders of the lymphopoietic system, including leukemia, lymphoma, multiple myeloma, and myeloproliferative neoplasms. The dysregulation of inflammatory factors or chronic inflamma...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-05-01
|
| Series: | Biomolecules |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2218-273X/15/5/716 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849711021354123264 |
|---|---|
| author | Yanquan Liu Huanwen Tang |
| author_facet | Yanquan Liu Huanwen Tang |
| author_sort | Yanquan Liu |
| collection | DOAJ |
| description | Malignant hematologic diseases, also referred to as hematologic tumors, encompass a series of malignant proliferative disorders of the lymphopoietic system, including leukemia, lymphoma, multiple myeloma, and myeloproliferative neoplasms. The dysregulation of inflammatory factors or chronic inflammatory responses plays an indispensable role in the onset and progression of these tumors. The C-X-C motif chemokine receptor (CXCR) serves as a key mediator of immune-inflammatory responses. Through its specific regulatory mechanisms, CXCR is involved in the transduction and activation of various signaling pathways, thereby mediating the malignant biological characteristics of blood tumor cells, such as uncontrolled proliferation, differentiation, invasion, migration, autophagy, and apoptosis. In the bone marrow microenvironment, CXCR plays a pivotal role. This review systematically analyzes and elucidates the roles and mechanisms of the CXCR family in hematologic malignancies, aiming to provide new insights into the biological mechanisms and clinical significance of these diseases. The CXCR family holds great potential as a molecular marker for both fundamental research and the clinical diagnosis and treatment of hematologic malignancies. |
| format | Article |
| id | doaj-art-e6dadf1bc3394f2fae7dfdf90f1f1178 |
| institution | DOAJ |
| issn | 2218-273X |
| language | English |
| publishDate | 2025-05-01 |
| publisher | MDPI AG |
| record_format | Article |
| series | Biomolecules |
| spelling | doaj-art-e6dadf1bc3394f2fae7dfdf90f1f11782025-08-20T03:14:45ZengMDPI AGBiomolecules2218-273X2025-05-0115571610.3390/biom15050716CXCR Family and Hematologic Malignancies in the Bone Marrow MicroenvironmentYanquan Liu0Huanwen Tang1Department of Hematology, The First Dongguan Affiliated Hospital of Guangdong Medical University, The First School of Clinical Medicine, Guangdong Medical University, Dongguan 523808, ChinaDepartment of Hematology, The First Dongguan Affiliated Hospital of Guangdong Medical University, Dongguan Key Laboratory of Environmental Medicine, School of Public Health, Guangdong Medical University, Dongguan 523808, ChinaMalignant hematologic diseases, also referred to as hematologic tumors, encompass a series of malignant proliferative disorders of the lymphopoietic system, including leukemia, lymphoma, multiple myeloma, and myeloproliferative neoplasms. The dysregulation of inflammatory factors or chronic inflammatory responses plays an indispensable role in the onset and progression of these tumors. The C-X-C motif chemokine receptor (CXCR) serves as a key mediator of immune-inflammatory responses. Through its specific regulatory mechanisms, CXCR is involved in the transduction and activation of various signaling pathways, thereby mediating the malignant biological characteristics of blood tumor cells, such as uncontrolled proliferation, differentiation, invasion, migration, autophagy, and apoptosis. In the bone marrow microenvironment, CXCR plays a pivotal role. This review systematically analyzes and elucidates the roles and mechanisms of the CXCR family in hematologic malignancies, aiming to provide new insights into the biological mechanisms and clinical significance of these diseases. The CXCR family holds great potential as a molecular marker for both fundamental research and the clinical diagnosis and treatment of hematologic malignancies.https://www.mdpi.com/2218-273X/15/5/716CXC chemokine receptorhematologic malignancieslymphopoietic systemcarcinogenic mechanismstherapeutic targets |
| spellingShingle | Yanquan Liu Huanwen Tang CXCR Family and Hematologic Malignancies in the Bone Marrow Microenvironment Biomolecules CXC chemokine receptor hematologic malignancies lymphopoietic system carcinogenic mechanisms therapeutic targets |
| title | CXCR Family and Hematologic Malignancies in the Bone Marrow Microenvironment |
| title_full | CXCR Family and Hematologic Malignancies in the Bone Marrow Microenvironment |
| title_fullStr | CXCR Family and Hematologic Malignancies in the Bone Marrow Microenvironment |
| title_full_unstemmed | CXCR Family and Hematologic Malignancies in the Bone Marrow Microenvironment |
| title_short | CXCR Family and Hematologic Malignancies in the Bone Marrow Microenvironment |
| title_sort | cxcr family and hematologic malignancies in the bone marrow microenvironment |
| topic | CXC chemokine receptor hematologic malignancies lymphopoietic system carcinogenic mechanisms therapeutic targets |
| url | https://www.mdpi.com/2218-273X/15/5/716 |
| work_keys_str_mv | AT yanquanliu cxcrfamilyandhematologicmalignanciesinthebonemarrowmicroenvironment AT huanwentang cxcrfamilyandhematologicmalignanciesinthebonemarrowmicroenvironment |